Loopbaan van Mary Lucus
Eerdere bekende functies van Mary Lucus
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SELECTIS HEALTH, INC. | Comptroller/Controller/Auditor | 01-04-2021 | 05-04-2023 |
| Financieel Directeur/CFO | 04-03-2022 | 05-04-2023 | |
| Bedrijfssecretaris | 31-10-2022 | 05-04-2023 | |
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Opleiding van Mary Lucus
| San Diego State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
Sectoraal
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SELECTIS HEALTH, INC. | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
- Beurs
- Insiders
- Mary Lucus
- Ervaring
